HLA DPB1 CWD Resolution
Also known as: CWD Resolution Typing
Use
DPB1 antigens may be correlated with certain disease states or other clinical conditions. Indicate in clinical information which antigen(s) is of interest. Also used for screening of transplant candidates and potential donors, transfusion of specifically compatible blood products, among others.
Special Instructions
If you have questions, please call 800-533-1037 (HLA customer service) for assistance in selecting the proper HLA test for the patient.
Limitations
The test is developed and its performance characteristics determined by Labcorp, but it has not been cleared or approved by the FDA. Rare or unusual allele combinations may not be ruled out. Alleles that encode identical protein sequences in the antigen recognition site may not be individually resolved even if they are common and well-documented alleles. Hence, there may be multiple alternative genotype results provided.
Methodology
NGS (Targeted)
Biomarkers
LOINC Codes
- 59017-4
- 49549-9
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
7 mL
Minimum Volume
3 mL
Container
Lavender-top (EDTA) tube
Storage Instructions
Maintain specimen at room temperature; protect from extreme heat or cold. Do not freeze.
Causes for Rejection
Hemolyzed specimen; clotted specimen; wrong specimen container